Enhertu Breast Cancer Treatment: Major Advances...

By HEOR Staff Writer

October 3, 2025

What is the impact of Enhertu breast cancer treatment for patients with early-stage HER2-positive breast cancer? Enhertu breast cancer treatment has shown a significant improvement in invasive disease-free survival (iDFS) compared to the prior sta...
Empowering Innovation: Clinical Trials Reform Strategies by EMA for 2025
Transforming Cancer Treatment: Implications of Subcutaneous Pembrolizumab App...
NIVOPOSTOP Trial Results: A Landmark Breakthrough in Head and Neck Cancer Tre...
CAPVAXIVE Pneumococcal Vaccine Delivers Strong Immune Response in At-Risk Youth
Oral Semaglutide Benefits: EMA Approves First Oral GLP-1 RA with Cardiovascul...
Innovative Strategies of MoonLake Immunotherapeutics HS in Targeting Inflamma...
AMALFI Trial: How Patch-Based ECG Monitoring Could Transform Remote Atrial Fi...
FDA Guidance on Overall Survival Assessment in Oncology Trials
Assessment of Glofitamab With Gemcitabine in DLBCL Reveals No Additional Benefit
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
Sanofi’s Rilzabrutinib Receives Orphan Designation for IgG4-Related Dis...
PADCEV KEYTRUDA Urothelial Cancer: Advancements in Survival Outcomes and Econ...